Cancer and COVID-19: Resources for Patients and Survivors

The 11th annual Ruesch Center Symposium

Save the Date for our Virtual Symposium – November 20-21, 2020

Learn More

Current Clinical Trials

Search our current GI clinical trials offered through the MedStar Georgetown Cancer Institute

View Clinical Trials

New Colon Cancer Concerns

Dr. Marshall talks with Today Show about why colon cancer is on the rise in young patients

View Today Show Segment with Dr. Marshall

Summer of Support Drive

Please help us keep the momentum going with a generous gift of any size today to our Summer of Support Drive!

More information

Dr. Marshall explains procedures MedStar and Georgetown have instituted to ensure your safety while you receive the best care possible Learn More

Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.




Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types

August 28th, 2020

Learn from the experts including Dr. John Marshall, Dr. Jamie Chaft, MD and Scot Niglio, MD, about current and emerging immuno-oncology biomarkers to guide selection of optimal cancer treatment across tumor types. Participate in the interactive CCO Webinar or watch the on-demand Webcast and download the slides. Listen to a podcast for answers to FAQs asked during the live Webinar.

No-Visitor Policies Are Bad Medicine

August 26th, 2020

According to Dr. John Marshall, “Cancer care is not elective; it has to keep going. One of the worst policies for our patients right now is this no-visitor policy. You are coming for a treatment, a clinic visit, or, worse yet, admitted to the hospital for end-of-life care or for some complex medical procedure related to your cancer, and yet you can’t have a caregiver, an advocate, sitting next to you in your room.”



Sign Up to receive all Ruesch updates directly in your Inbox

We will deliver our quarterly newsletter, monthly updates and other announcements to your Inbox with information on upcoming special events, current clinical trials and cutting edge research and trends in the GI cancer field.